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NC-ND license (http://creativecommoSummary Colorectal cancer is seldom accompanied by venous tumor thrombosis, and little is
known about the features of venous tumor thrombosis in colorectal cancer. However, some re-
ports show that colorectal cancer patients can develop venous tumor thrombosis and warn cli-
nicians not to overlook this complication. In this report, we perform a review of 43 previously
reported cases and investigate the characteristics of colorectal cancer accompanied by venous
tumor thrombosis. The histological type of more than half of the cases was moderately differ-
entiated adenocarcinoma, which is known to be aggressive. Among 41 cases with available
data on liver metastasis, eight patients had synchronous liver metastasis, and liver metastatic
recurrence after surgical resection was indicated in 10 patients. This liver metastatic rate was
high compared to general colorectal cancer. However, 11 of 43 patients with venous tumor
thrombosis could survive for more than 2 years after the diagnosis, although five of the 11 pa-
tients had liver metastasis. A long survival can be anticipated for patients following complete
tumor resection and adjuvant chemotherapy. A greater accumulation of cases will help eluci-
date the characteristics of colorectal cancer with venous tumor thrombosis and improve the
treatment strategy.
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Figure 1 Age distribution of the 43 cases.
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Venous tumor thrombosis occasionally accompanies renal
cell carcinoma, adrenal cortical carcinoma, hepatoma,
pancreatic carcinoma, gastric carcinoma, Wilms’ tumor,
and testicular carcinoma1e3; however, colorectal cancer
with tumor thrombosis in the portal or superior, inferior
mesenteric vein is quite rare.4 Sato et al5 reported that
venous tumor thrombosis was detected in three cases
(1.7%) out of 176 patients with advanced colorectal cancer.
Regarding renal cell carcinoma, it has a high propensity to
invade adjacent renal veins and the inferior vena cava.
Renal cell carcinoma is an aggressive neoplasm that causes
dissemination to the renal veins and inferior vena cava in
24% and 12% of all cases, respectively, and this venous
involvement implies a poor prognosis.6,7 Regarding hepatic
cell cancers, portal vein tumor thrombosis is a risk factor of
a poor prognosis.2
As diagnostic methods, contrast-enhanced computed
tomography (CT), magnetic resonance, and ultrasound (US)
are useful to detect venous tumor thrombosis.7e11 Venous
tumor thrombosis may be noted on CT as a low-attenuation
area; however, blood clot thrombosis remains to be diag-
nosed.12e15 Recently, the usefulness of positron emission
tomography (PET) in detecting venous tumor thrombosis
has been shown by intense radiotracer accumulation, which
distinguishes thrombosis from blood clots.1,16e19
A few reports have shown that colorectal cancer can
develop venous tumor thrombosis and warn not to overlook
this complication. Little is known about the causes of
venous tumor thrombosis and the characteristics or prog-
nosis of colorectal cancer with venous tumor thrombosis. In
this report, we perform a literature review and investigate
the characteristics of colorectal cancer accompanied by
venous tumor thrombosis.
2. Analysis of the cases
Only 43 cases of venous tumor thrombosis in colorectal
cancer patients were found in a search of the pertinent
literature, most of which were reported in Japanese liter-
ature.4,5,12,14,19,20e53 According to the 1997 Annual of
Pathological Autopsy Cases in Japan, the incidence of
portal vein metastasis in colorectal cancer was reported to
be 0.6% (9/1604). The report also revealed that the inci-
dence of liver metastasis from colorectal cancer was 38.1%
(611/1604) and showed the rate of portal vein thrombosis
to be fairly low.54 In 2010, Sato et al5 showed in their
Japanese report that three cases (1.7%) of 176 patients
with advanced colorectal carcinoma were found to have
venous tumor thrombosis.
2.1. Clinical data
We identified 43 cases of colorectal cancer with venous
tumor thrombosis from international and domestic reports
(written in Japanese) from 1992 to 2014. Although colo-
rectal cancer with venous tumor thrombosis remains
rare, the number of reports of these cases is increasing
because of the development of diagnostic imaging tech-
nology. Among 43 patients, there was a slight femalePlease cite this article in press as: Otani K, et al., Colorectal cancer
http://dx.doi.org/10.1016/j.asjsur.2016.07.013predominance [n Z 24 (female) vs. n Z 19 (male)]. Most
patients were in their 60s (n Z 16) or 70s (n Z 15)
(Figure 1), and the median age was 67 years (range,
47e84 years). Regarding the location of the tumor, the
ascending colon (n Z 12) and rectum (n Z 11) were the
most frequent sites, followed by the sigmoid colon
(n Z 8), transverse colon (n Z 6), and descending colon
(n Z 5) (Figure 2). No cases of cecum cancer with venous
tumor thrombosis were reported. The invaded vein was
dependent on the tumor sitedthat is, ascending and
transverse colon cancer invaded the superior mesenteric
vein (n Z 17; including the ileocolic vein and right colic
vein), whereas descending, sigmoid colon, and rectal
cancer invaded the inferior mesenteric vein (nZ 24). One
case with diffuse colon cancer, which spread over the
transverse, descending, sigmoid colon, developed tumor
thrombosis in the portal vein,28 and one case of rectal
cancer that invaded the internal iliac vein was observed.19
Regarding the frequency of cancer in each part of the
colorectum (right hemicolon: 29.5% vs. left hemicolon:
70.5%55), the superior mesenteric vein was thus consid-
ered to more likely be invaded by tumor thrombosis.
2.2. Pathological type
Interestingly enough, the histological type of more than
half of the cases was moderately differentiated adeno-
carcinoma (Figure 3). In epidemiological studies, the his-
tological types of colorectal cancer are commonly divided
into two types: well differentiated (including well and
moderately differentiated type) versus poorly differenti-
ated (including poorly differentiated, signet ring cell, and
mucinous carcinoma). Previous reports about clinico-
pathological studies of colorectal cancer revealed that
patients with well differentiated tumors have a better
prognosis compared to those with poorly differentiated
tumors.56e58 Poorly differentiated adenocarcinomas of
the rectum are considered to behave more aggressively
than well or moderately differentiated adenocarci-
nomas.59 However, compared to well differentiated
adenocarcinoma, moderately differentiated carcinomawith venous tumor thrombosis, Asian Journal of Surgery (2016),
Figure 2 Location of the cancer. A Z ascending colon;
D Z descending colon; R Z rectum; S Z sigmoid colon;
T Z transverse colon. One case had diffuse colon cancer ac-
cording to a histopathological evaluation of the colonoscopic
biopsy specimens. Its histological type was well differentiated
adenocarcinoma.28
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Moreover, moderately differentiated tumors were associ-
ated with higher serum carcinoembryonic antigen levels
than both well and poorly differentiated tumors.63,64
Some studies reported that the circulating carcinoem-
bryonic antigen level is associated with the ability of
colorectal cancer to metastasize to the liver.65,66 These
previous results support our finding that the predominant
histological type of developing venous tumor thrombosis
from colorectal cancer is the moderately differentiated
type. Thus, venous tumor thrombosis may indicate the
aggressiveness of moderately differentiated adenocarci-
noma. Iida62 studied 408 colorectal cancer patients and
reported the occurrence ratio of each histopathologicalFigure 3 Histological type of the cancer. endocrine Z end
mucZmucinous adenocarcinoma; porZ poorly differentiated; we
Among these histological types in 35 patients, moderately differen
Please cite this article in press as: Otani K, et al., Colorectal cancer
http://dx.doi.org/10.1016/j.asjsur.2016.07.013type; well differentiated cancer comprised 70.3% of the
cases, moderately differentiated cancer 16.9%, poorly
differentiated cancer 3.4%, and mucinous adenocarci-
noma 6.6%. Considering these frequencies, poorly differ-
entiated adenocarcinoma also has an aggressive potential
of developing venous tumor thrombosis.
2.3. Liver metastasis
All colorectal cancer cases with venous tumor thrombosis
carry advanced cancer and show microscopic invasion to
the vein around the tumor (with the exception of one
case27). We speculated that venous tumor thrombosis may
be a strong risk factor for liver metastasis; however, the
incidence of synchronous liver metastasis was only 19.5% of
the cases (8 out of 41 cases; the data for 2 cases were
unclear). Because the incidence liver metastasis for all
colorectal cancer (including in the early stage) was only
10.9%,55 this result does not indicate a high frequency for
colorectal cancer with venous tumor thrombosis consisting
of only advanced cancers. We compared the incidence of
liver metastasis (including synchronous and metachronous)
and found no apparent difference between each patho-
logical type of cancer under the condition of bearing
venous tumor thrombosis (Table 1).
After complete surgical resection of the tumor, 10
cases (24.4%) had liver metastatic recurrence. Regarding
this recurrence rate, cancer with venous tumor thrombosis
leads to a high risk for liver metastasis compared to gen-
eral colorectal cancer (liver metastatic recurrence
rate Z 7.1%66). Among these cases, seven cases under-
went adjuvant chemotherapy after surgical resection.
However, 14 cases had no recurrence after surgical
resection followed by adjuvant chemotherapy. However,
owing to the absence of detailed data of the treatment in
14 cases, these data do not indicate that one-third of the
patients had liver metastatic recurrence even after com-
plete surgical resection and adjuvant chemotherapy.ocrine cell carcinoma; mod Z moderately differentiated;
lZ well differentiated. Data were not available for eight cases.
tiated adenocarcinoma comprised the majority.
with venous tumor thrombosis, Asian Journal of Surgery (2016),
Table 1 Pathological types and liver metastasis.
Pathological type Liver metastasis Total
Positive Negative No data
wel 2 2 1 5
mod 8 12 0 20
por 3 3 0 6
muc 1 1 0 2
endo 1 1 0 2
no data 2 5 1 8
Total 17 24 2 43
Data of the liver metastatic state were not available for two
cases.
endo Z endocrine cell carcinoma; mod Z moderately differ-
entiated; muc Z mucinous adenocarcinoma; por Z poorly
differentiated; Wel Z well differentiated.
Figure 4 Survival of patients with or without liver metas-
tasis. Survival time of 14 patients with liver metastasis and 13
patients without liver metastasis are represented. No data of
the survival time was available for three patients with liver
metastasis and 11 patients without liver metastasis. In two
patients, the liver metastatic state was unknown. Gray bars
represent the length of survival for patients alive when their
report was described. Black bars represent patients who died
and represent the accurate survival time.
4 K. Otani et al.
+ MODEL2.4. Treatment
In treatment, it is first important to recognize the existence
of tumor thrombosis in the drainage vein from the cancer
by CT, PET, or US imaging prior to the operation. Not to
leave the tumor thrombosis, both a careful pre-evaluation
of the extension level of the thrombosis and an examination
of the venous lumen of the resected specimen are neces-
sary. To avoid the movement of cancer fragments during
surgical resection, initial tying of the vein with tumor
thrombus may be ideal. Among the 43 patients analyzed in
this review, complete tumor resection was performed in 32
patients (74.4%). In two patients, the primary tumor with
venous thrombosis was resected, leaving liver metastasis.
Surgical resection was not performed in four patients, and
the treatment was unclear in five patients. The use of
laparoscopy-assisted colectomy is increasing. It is difficult
to recognize the region of tumor thrombus by touching with
laparoscopic forceps. Moreover, the manipulation of pulling
out the tumor from a small incision in the abdominal wall
squeezes the tumor, which could easily result in the
movement of cancer fragments. Therefore, a prudent
strategy for resection with no residual cancer is needed.
For patients with venous tumor thrombosis, adjuvant
chemotherapy even after complete resection should be
considered because of the aggressive character of cancer
with tumor thrombosis, which may be a high risk factor of
metastasis and recurrence. In this series, adjuvant chemo-
therapy was performed in 21 of 32 cases that underwent
complete tumor resection (65.6%); four cases did not
receive adjuvant chemotherapy; and detailed information
regarding chemotherapy was unavailable for seven cases.
2.5. Prognosis
The prognosis of patients with venous tumor thrombosis of
colorectal cancer is unclear. When considering that venous
tumor thrombosis may indicate aggressive cancer, the
prognosis of the patients may be poor. However, following
surgical complete resection with adjuvant chemotherapy,
some patients achieved a long survival.37,44 It is difficult to
confirm the relationship between the survival time and the
existence of liver metastasis or the treatment procedurePlease cite this article in press as: Otani K, et al., Colorectal cancer
http://dx.doi.org/10.1016/j.asjsur.2016.07.013because of the small number of cases and a short obser-
vation time. However, in reports with this information
available, 11 patients among 43 patients with venous tumor
thrombosis could survive for more than 2 years after the
diagnosis, although five patients had liver metastasis
(Figure 4). The mean survival time of those who had liver
metastasis was 22.5 months. This survival time is not poor
for patients with Stage IV colorectal cancer. Recently,
especially after 2009, the number of patients treated with
adjuvant chemotherapy appears to be increasing. An
improvement in the survival of patients with colorectal
cancer accompanied by venous tumor thrombosis is antici-
pated. A greater accumulation of evidence regarding the
treatment procedure, incidence of recurrence or metas-
tasis, and survival time will help us determine the appro-
priate strategy for colorectal cancer with venous tumor
thrombosis.
The prognosis of patients with colorectal cancer
accompanied by venous tumor thrombosis is not always
poor. A long survival can be anticipated for patientswith venous tumor thrombosis, Asian Journal of Surgery (2016),
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therapy. Surgeons should continue their efforts to remove
the tumor by resection and chemical offense.
3. Conclusion
Colorectal cancer with venous tumor thrombosis is rare,
and little is known about its features. In this review, we
found that moderately differentiated adenocarcinoma has
the potential to develop venous tumor thrombosis.
Although liver metastasis often accompanies venous tumor
thrombosis, complete tumor resection and adjuvant
chemotherapy can improve the prognosis. A greater accu-
mulation of cases will help elucidate the characteristics of
cancer with venous tumor thrombosis and improve the
treatment strategy.
References
1. Radecka E, Brekkan E, Juhlin C, Nilsson L, Sundin A,
Magnusson A. An unusual case of tumor thrombus in the inferior
vena cava. A case report. Acta Radiol. 2003;44:160e161.
2. Izumi R, Shimizu K, Ii T, et al. Prognostic factors of hepato-
cellular carcinoma in patients undergoing hepatic resection.
Gastroenterology. 1994;106:720e727.
3. Siegelbaum MH, Moulsdale JE, Murphy JB, McDonald GR. Use of
magnetic resonance imaging scanning in adrenocortical carci-
noma with vena caval involvement. Urology. 1994;43:869e873.
4. Tanaka A, Takeda R, Mukaihara S, et al. Tumor thrombi in the
portal vein system originating from gastrointestinal tract can-
cer. J Gastroenterol. 2002;37:220e228.
5. Sato O, Kiba M, Tazoe J, et al. Rinsho Housyasen. 2010;55:
420e426 (in Japanese).
6. Zisman A, Wieder JA, Pantuck AJ, et al. Renal cell carcinoma
with tumor thrombus extension: biology, role of nephrectomy
and response to immunotherapy. J Urol. 2003;169:909e916.
7. Ergen FB, Hussain HK, Caoili EM, et al. MRI for preoperative
staging of renal cell carcinoma using the 1997 TNM classifica-
tion: comparison with surgical and pathologic staging. AJR Am
J Roentgenol. 2004;182:217e225.
8. Laissy JP, Menegazzo D, Debray MP, et al. Renal carcinoma:
diagnosis of venous invasion with Gd-enhanced MR venography.
Eur Radiol. 2000;10:1138e1143.
9. Sheth S, Scatarige JC, Horton KM, Corl FM, Fishman EK. Current
concepts in the diagnosis and management of renal cell car-
cinoma: role of multidetector CT and three-dimensional CT.
Radiographics. 2001;21:S237eS254.
10. Gupta NP, Ansari MS, Khaitan A, et al. Impact of imaging and
thrombus level in management of renal cell carcinoma
extending to veins. Urol Int. 2004;72:129e134.
11. Spahn M, Portillo FJ, Michel MS, et al. Color duplex sonography
vs. computed tomography: accuracy in the preoperative eval-
uation of renal cell carcinoma. Eur Urol. 2001;40:337e342.
12. Kanzaki A, Hirota M, Okamoto K, Yamashita K, Sato T,
Ichihara T. A case of the transverse colon cancer combined
with tumor thrombus in superior mesenteric vein and colon
perforation. Nippon Shoukakigeka Gakkai Zassi (Jpn J Gastro-
enterol Surg). 2009;42:1436e1441 (in Japanese with English
abstract).
13. Tomono H, Nimura Y, Kamiya J, et al. A case of ascending colon
cancer with a tumor thrombus in the superior mesenteric vein.
Nihon Shokakibyo Gakkai Zasshi. 1993;90:2117e2121 (in
Japanese).
14. Imai M, Okawada K, Kato T, Takahashi G, Kaneko M. Eizo-Joho
Med. 1993;25:1322e1324 (in Japanese).Please cite this article in press as: Otani K, et al., Colorectal cancer
http://dx.doi.org/10.1016/j.asjsur.2016.07.01315. Subramanyam BR, Balthazar EJ, Lefleur RS, Horii SC,
Hulnick DH. Portal venous thrombosis: correlative analysis of
sonography, CT and angiography. Am J Gastroenterol. 1984;79:
773e776.
16. Hain SF, Gleadle J, Maisey MN. F-18 fluorodeoxyglucose PET in
the diagnosis of vascular invasion in renal cell carcinoma. Clin
Nucl Med. 1999;24:819e820.
17. Nguyen BD. Positron emission tomography imaging of renal vein
and inferior vena cava tumor thrombus from renal cell carci-
noma. Clin Nucl Med. 2005;30:107e109.
18. Kaida H, Ishibashi M, Kurata S, Uchida M, Hayabuchi N.
Tumor thrombus in the inferior vena cava from colon can-
cer detected by 18F-FDG-PET. Ann Nucl Med. 2007;21:
185e188.
19. Gupta P, Kramer EL, Ponzo F. FDG uptake in tumor thrombus in
inferior vena cava from rectal cancer on positron emission
tomography. Clin Nucl Med. 2005;30:342e343.
20. Tomono H, Nimura Y, Kamiya J, et al. Nippon Syoukakibyou
Gakkai Zassi. 1992;89:2329 (in Japanese).
21. Tomono H, Nimura Y, Kamiya J, et al. Nippon Syoukakibyou
Gakkai Zassi. 1993;90:2117e2121 (in Japanese).
22. Kanemura E, Obi Y, Kito F, Fukushima T, Sashima T, Sano J.
Syujyutu. 1997;51:1559e1562 (in Japanese).
23. Nakatsuta K, Takayama W, Imazeki H, et al. Nippon Daicho-
koumonnbyou Gakkai Zassi. 1998;51:896 (in Japanese).
24. Komatsuda T, Ishida H, Konno K, et al. Chouonpaigaku. 2001;
28:J151 (in Japanese).
25. Fujii M, Nojima M, Kobayashi T. Nippon Rinshogeka Gakkai
Zassi. 2000;61:2701e2704 (in Japanese).
26. Watanuki Y, Tsujii Y, Tanaka S, Tamaoki M, Nishikawa M,
Morii K. Chouonpaigaku. 2001;28:J151 (in Japanese).
27. Higuchi R, Inoue Y, Eguchi R, et al. Gekachiryou. 2002;37:
220e228 (in Japanese).
28. Nakase H, Kawanami C, Itoh T, et al. Diffuse colon cancer with
tumor thrombus in the portal vein. Gastrointest Endosc. 2002;
55:239e240.
29. Okumura T, Kawabata T, Morizumi M, et al. Nippon Rinshogeka
Gakkai Zassi. 2003;64:1785 (in Japanese).
30. Nishihara Y, Kodama M, Katsuragi M, et al. Nippon Igakuhou-
syasen Gakkai Zassi. 2004;64:238e239 (in Japanese).
31. Kitaoka H, Osawa T, Nakata H, Yokoyama M, Ishida H. Nippon
Daichokoumonnbyou Gakkai Zassi. 2005;58:585 (in Japanese).
32. Deguchi T, Yano H, Miyake M, Saito Y. Syujyutsu. 2005;59:
1883e1886 (in Japanese).
33. Katsumoto Y, Ito N, Maruyama K, Yoshihara W. Sigmoid colon
cancer with a tumor thrombosis in the splenic vein e a case
report. Jpn J Cancer Chemother. 2006;33:1974e1976 (in Jap-
anese with English abstract).
34. Kawashima K, Endo W, Itakura Y, Wada N, Yokota K. Nippon
Rinshogeka Gakkai Zassi. 2007;68:933e937 (in Japanese).
35. Yamagami H, Masuko H, Kondo Y, Okada K, Ishizu H, Honnma S.
Nippon Daichokoumonnbyou Gakkai Zassi. 2009;62:38e43 (in
Japanese).
36. Fukushima K, Sugawara H, Hirano Y, et al. Nippon Rinsyoge-
kagakkai Zassi. 2009;70:543 (in Japanese).
37. Matsumoto J, Kojima T, Hiraguchi E, Abe M. Portal vein tumor
thrombus from colorectal cancer with no definite metastatic
nodules in liver parenchyma. J Hepatobil Pancreat Surg. 2009;
16:688e691.
38. Tanoue Y, Tanaka N, Suzuki Y, Hata S, Yokota A. A case report
of endocrine cell carcinoma in the sigmoid colon with inferior
mesenteric vein tumor embolism. World J Gastroenterol.
2009;15:248e251.
39. Inuino Y, Tani S, Suzuki S, Aoki T, Yamamoto Y, Kobayashi T.
Hokkaido Geka Zassi. 2010;55:63e64 (in Japanese).
40. Matsuda M, Shida D, Maeshiro T, Miyamoto Y, Inoue A,
Umekita N. Nippon Shoukakigeka Ggakkai Zassi. 2010;65:430
(in Japanese).with venous tumor thrombosis, Asian Journal of Surgery (2016),
6 K. Otani et al.
+ MODEL41. Inose S, Kumazawa K, Takaoka K, et al. A case of macroscopic
portal vein tumor thrombi from colorectal liver metastasis
undergoing liver resection after chemotherapy. Nippon Geka-
keirenngoukaisi. 2010;35:632e636 (in Japanese with English
abstract).
42. Kawada R, Kimura S, Nishigaki Y, et al. Nippon Shoukakibyou
Gakkai Zassi. 2011;108:A880 (in Japanese).
43. Nasu K, Shida D. A case of rectal cancer with a tumor throm-
bosis in the inferior mesenteric vein. Nippon Daichokou-
monbyou Gakkai Zassi. 2012;65:341e347 (in Japanese with
English abstract).
44. Jimi S, Kuga H, Watabe J, et al. A case of rectal cancer
accompanied by tumor thrombus in the inferior mesenteric
vein. Nippon Shoukakigeka Gakkai Zassi (Jpn J Gastro-
enterol Surg). 2012;45:1066e1073 (in Japanese with English
abstract).
45. Shintani D, Tajima Y, Baba H, et al. Colon cancer with portal
vein tumor thrombosis e a case report and review of the
literature. Gan to Kagakuryouhou (Jpn J Cancer Chemother).
2012;39(12):2243e2245 (in Japanese with English abstract).
46. Imaizumi K, Yoshimura T, Tsukahara K, et al. Nippon Rinsyo-
geka Gakkai Zassi. 2012;73:817 (in Japanese).
47. Hashimoto Y, Shibazaki S, Oka T, Naitou S, Denba M. Nippon
Rinsyogeka Gakkai Zassi. 2012;73:680 (in Japanese).
48. Ohgaki K, Kamienami I, Fujiie M, et al. Rinsyo to Kenkyu. 2013;
90:601e604 (in Japanese).
49. Kouroki S, Kawano F, Senba H, et al. Nippon Rinsyougeka
Gakkai Zassi. 2013;74:1039 (in Japanese).
50. Kumamoto K, Hoshi N, Watanabe Y, et al. Nippon Rinsyougeka
Gakkai Zassi. 2013;74:978 (in Japanese).
51. Toyoda N, Hoshino Y. Nippon Daichokoumonbyou Gakkai Zassi.
2013;66:886 (in Japanese).
52. Ohashi Y, Oki G, Inoue Y, et al. Nippon Rinsyougeka Gakkai
Zassi. 2013;74(7):2034 (in Japanese).
53. Kato K, Kuraya D, Funakoshi T, et al. Nippon Rinsyogeka Gakkai
Zassi. 2013;74(2):591 (in Japanese).
54. The Japanese Society of Pathology, ed. Annual of the Patho-
logical Autopsy Cases in Japan. vol. 40. Aichi: Jinshikai; 1998
(JaneDec 1997) (in Japanese).Please cite this article in press as: Otani K, et al., Colorectal cancer
http://dx.doi.org/10.1016/j.asjsur.2016.07.01355. Japanese Society for Cancer of the Colon and Rectum (JSCCR)
guidelines 2014 for the treatment of colorectal cancer. 2014.
56. Brandao O, Sobrinho-Simoes MA, Serrao D, Moutinho-Ribeiro M,
Azevedo C. Prognosis in colorectal carcinoma. A reassessment
of the pathologist’s role. Pathol Res Pract. 1985;180:506e510.
57. Cohen AM, Wood WC, Gunderson LL, Shinnar M. Pathological
studies in rectal cancer. Cancer. 1980;45:2965e2968.
58. Jass JR, Atkin WS, Cuzick J, et al. The grading of rectal cancer:
historical perspectives and a multivariate analysis of 447 cases.
Histopathology. 1986;10:437e459.
59. Talbot IC, Ritchie S, Leighton M, Hughes AO, Bussey HJ,
Morson BC. Invasion of veins by carcinoma of rectum: method
of detection, histological features and significance. Histopa-
thology. 1981;5:141e163.
60. Murray D, Hreno A, Dutton J, Hampson LG. Prognosis in colon
cancer: a pathologic reassessment. Arch Surg. 1975;110:
908e913.
61. Newland RC, Chapuis PH, Pheils MT, MacPherson JG. The
relationship of survival to staging and grading of colorectal
carcinoma: a prospective study of 503 cases. Cancer. 1981;47:
1424e1429.
62. Iida A. The relationship between pathological types and sur-
vival of colo-rectal carcinoma. Nippon Daichokoumonbyou
Gakkai Zassi. 1990;43:533e541 (in Japanese with English
abstract).
63. Rognum TO. CEA, tumour differentiation and DNA ploidy
pattern. Scand J Gastroenterol Suppl. 1988;149:166e178.
64. Hamada Y, Yamamura M, Hioki K, Yamamoto M, Nagura H,
Watanabe K. Immunohistochemical study of carcinoembryonic
antigen in patients with colorectal cancer. Correlation with
plasma carcinoembryonic antigen levels. Cancer. 1985;55:
136e141.
65. Wagner HE, Thomas P, Wolf BC, Zamcheck N, Jessup JM,
Steele Jr GD. Characterization of the tumorigenic and meta-
static potential of a poorly differentiated human colon cancer
cell line. Invasion Metastasis. 1990;10:253e266.
66. Jessup JM, Thomas P. Carcinoembryonic antigen: function in
metastasis by human colorectal carcinoma. Cancer Metastasis
Rev. 1989;8:263e280.with venous tumor thrombosis, Asian Journal of Surgery (2016),
